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Abstract 
Bovine granulosa cells are often exposed to energy stress, due to the energy demands of lactation, and exposed to 
lipopolysaccharide from postpartum bacterial infections. Granulosa cells mount innate immune responses to 
lipopolysaccharide, including the phosphorylation of mitogen-activated protein kinases and production of pro-
inflammatory interleukins. Cellular energy depends on glycolysis, and energy stress activates intracellular AMPK 
(AMP-activated protein kinase), which in turn inhibits mTOR (mechanistic target of rapamycin). Here, we tested 
the hypothesis that manipulating glycolysis, AMPK or mTOR to mimic energy stress in bovine granulosa cells 
limits the inflammatory responses to lipopolysaccharide. We inhibited glycolysis, activated AMPK or inhibited 
mTOR in granulosa cells isolated from 4–8 mm and > 8.5 mm diameter ovarian follicles, and then challenged the 
cells with lipopolysaccharide and measured the production of interleukins IL-1α, IL-1β, and IL-8. We found that 
inhibiting glycolysis with 2-deoxy-D-glucose reduced lipopolysaccharide-stimulated IL-1α > 80%, IL-1β > 90%, 
and IL-8 > 65% in granulosa cells from 4–8 mm and > 8.5 mm diameter ovarian follicles. Activating AMPK with 
AICAR also reduced lipopolysaccharide-stimulated IL-1α > 60%, IL-1β > 75%, and IL-8 > 20%, and shortened 
the duration of lipopolysaccharide-stimulated phosphorylation of the mitogen-activated protein kinase ERK1/2 
and JNK. However, only the mTOR inhibitor Torin 1, and not rapamycin, reduced lipopolysaccharide-stimulated 
IL-1α and IL-1β. In conclusion, manipulating granulosa cell energy metabolism with a glycolysis inhibitor, an 
AMPK activator, or an mTOR inhibitor, limited inflammatory responses to lipopolysaccharide. Our findings 
imply that energy stress compromises ovarian follicle immune defences. 
Introduction 
Ovarian follicle function is often perturbed by energy stress and bacterial infections in postpartum dairy cows 
(Leroy, et al. 2008, Sheldon, et al. 2019, Sheldon, et al. 2002). Granulosa cells in ovarian follicles are exposed to 
energy stress when cows are unable to consume enough food to meet their energy demands, around the time of 
parturition and during lactation. These granulosa cells are then also exposed to lipopolysaccharide (LPS) if Gram-
negative bacteria proliferate in the uterus, mammary gland, or rumen during the postpartum period (Bromfield, et 
al. 2015, Piersanti, et al. 2019). In the absence of immune cells within ovarian follicles, the granulosa cells are 
responsible for innate immunity and mounting inflammatory responses to LPS (Bromfield and Sheldon 2011, 
Herath, et al. 2007). However, whether energy stress alters granulosa cell inflammatory responses to LPS is 
unclear. 
Granulosa cells are central to the emergence and development of 4–8 mm diameter ovarian follicles, selection and 
growth of dominant follicles > 8.5 mm diameter, and ovulation of competent oocytes (Fortune 1994, Ginther, et 
al. 1996). However, postpartum uterine disease reduces follicle growth rate and oestradiol secretion, inhibits 
ovulation, and reduces conception rates (LeBlanc, et al. 2002, Sheldon, et al. 2019, Sheldon, et al. 2002). Animals 
with uterine disease have LPS in their follicular fluid, and intrafollicular injection of LPS reduces follicle growth 
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rate and delays ovulation (Cheong, et al. 2017, Gindri, et al. 2019, Herath, et al. 2007, Piersanti, et al. 2019). 
Other sources of LPS include mastitis, ruminal acidosis, and intestinal barrier dysfunction (Bidne, et al. 2018, 
Dosogne, et al. 2002, Khafipour, et al. 2009). When LPS binds to Toll-like receptor 4 (TLR4), immune cells 
release inflammatory cytokines, such as interleukins IL-1 and IL-6, and the chemokine IL-8 (Moresco, et al. 
2011). However, healthy ovarian follicles lack immune cells within the membrana granulosa (Bromfield and 
Sheldon 2011, Irving-Rodgers, et al. 2001, Spanel-Borowski, et al. 1997). Instead, granulosa cells express TLR4, 
and LPS activates mitogen-activated protein kinase (MAPK) signalling and stimulates the production of IL-1β, 
IL-6 and IL-8 (Bromfield and Sheldon 2011, Herath, et al. 2007, Price, et al. 2013, Price and Sheldon 2013). As 
well as being pro-inflammatory mediators IL-1α, IL-1β, IL-6 and IL-8 affect ovarian follicle growth and function 
(Gérard, et al. 2004, Spicer and Alpizar 1994, Uri-Belapolsky, et al. 2014). 
Energy stress is caused by energy demand exceeding supply around the time of parturition and during lactation. 
This energy stress impairs immune cell function, perturbs ovarian follicle growth and function, and increases the 
risk of uterine disease (Beam and Butler 1997, Hammon, et al. 2006, LeBlanc 2012, Leroy, et al. 2008, Leroy, et 
al. 2004). Inflammatory responses to LPS are also energetically demanding. An extra 2.1 Kg/d glucose is required 
to respond to LPS infusion, which is comparable with 2.7 Kg/d glucose needed to produce 40 litres milk (Habel 
and Sundrum 2020, Kvidera, et al. 2017). Cellular energy metabolism is regulated by glycolysis, AMPK (AMP-
activated protein kinase), and mTOR (mechanistic target of rapamycin) (Hardie, et al. 2012, Murray, et al. 2015, 
O'Neill, et al. 2016, Zoncu, et al. 2011). The first enzyme in glycolysis, hexokinase, controls the rate of conversion 
of glucose to pyruvate, to supply the Krebs cycle and generate ATP. During energy stress, increased ratios of 
AMP:ATP results in phosphorylation of AMPK, which stimulates catabolic pathways such as glycolysis, and 
inhibits anabolic pathways that consume ATP such as protein synthesis (Hardie, et al. 2012). Phosphorylated 
AMPK also inhibits mTOR, which further limits anabolic pathways (Hardie, et al. 2012, Zoncu, et al. 2011).  
Metabolism and immunity are highly integrated, with energy stress altering immune cell responses to LPS (Dror, 
et al. 2017, Lachmandas, et al. 2016, Murray, et al. 2015, O'Neill, et al. 2016). An example of immunometabolism 
is that inhibiting glycolysis with 2-deoxy-D-glucose suppresses LPS-stimulated IL-1β in murine macrophages 
(Tannahill, et al. 2013). However, the role of immunometabolism in the ovary is unclear. The present study aimed 
to explore whether energy stress alters inflammatory responses to LPS in granulosa cells. We hypothesized that 
manipulating glycolysis, AMPK or mTOR to mimic energy stress in granulosa cells would limit the inflammatory 
responses to lipopolysaccharide. To test this hypothesis, we used bovine granulosa cells isolated from 4–8 mm 
and > 8.5 mm diameter ovarian follicles. We treated cells with small molecules to inhibit glycolysis, activate 
AMPK or inhibit mTOR, and then challenged the cells with LPS to measure their IL-1α, IL-1β and IL-8 
inflammatory responses. 
Materials and Methods 
Ethical statement 
Ovaries were collected from cattle after slaughter and processing, during the normal work of a commercial 
slaughterhouse, with approval from the United Kingdom Department for Environment, Food and Rural Affairs 
under the Animal By-products Registration (EC) No. 1069/2009 (registration number U1268379/ABP/OTHER). 
Granulosa cell culture 
Ovaries were collected within 15 min of slaughter from post pubertal, non-pregnant, healthy mixed-breed beef 
heifers. Ovaries were transported to the laboratory in Medium 199 (Thermo Fisher Scientific, Loughborough, 
UK) supplemented with 1% Antibiotic Antimycotic Solution (Merck, Gillingham, UK) and 0.1% bovine serum 
albumin (BSA; Merck).  
Granulosa cells were isolated and cultured as described previously (Price, et al. 2013). Briefly, ovaries were first 
rinsed in 70% ethanol and then sterile phosphate buffered saline (PBS; Thermo Fisher Scientific). Mural granulosa 
cells were then aspirated from follicles using a sterile 20-gauge needle and 5 ml LPS-free syringe (BD Medical, 
Oxford, UK) into collection medium, comprising Medium 199 supplemented with 0.5% w/v BSA, 25 mM HEPES 
(4-[2-hydroxyethyl] piperazine-1-ethanesulfonic acid), 1% Antibiotic Antimycotic Solution, and 0.005% w/v 
heparin (all Merck). Granulosa cells were aspirated from 4–8 mm diameter follicles to represent cells from 
emerged follicles, and > 8.5 mm diameter follicles to represent cells from dominant follicles (Fortune 1994). 
Granulosa cells were pooled from the ovaries of 10–20 animals, and washed twice in granulosa cell culture 
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medium, comprising Medium 199 (Thermo Fisher Scientific; 5.55 mM glucose) supplemented with 10% heat-
inactivated fetal bovine serum (Biosera, Ringmer, UK), 1% Antibiotic Antimycotic Solution, 1% Insulin-
Transferrin-Selenium (Corning, Palo Alto, USA) and, 2 mM glutamine (GlutaMAX, Thermo Fisher Scientific). 
The cells were counted and seeded into 24-well plates (TPP, Trasadingen, Switzerland) at a density of 750,000 
cells in 0.5 ml of granulosa cell culture medium. The cells were incubated at 38.5°C, in a humidified atmosphere 
of air containing 5% CO2. 
Granulosa cell treatment and challenge 
After an initial 18 h culture period, the medium was aspirated, and the cells were cultured with vehicle or 
treatments in 0.5 ml of granulosa cell culture medium. The experimental rationale was to use small molecules to 
manipulate glycolysis, AMPK or mTOR, or to alter the glucose supply, and then challenge the cells with LPS to 
evaluate inflammation. The first enzyme in the glycolysis pathway, hexokinase, was inhibited by treating cells 
for 2 h with 50–1000 µM 2-deoxy-D-glucose (Merck) to model energy stress, as described previously (Lee, et al. 
2020, Tannahill, et al. 2013, Zhao, et al. 2017). Subsequent experiments used 1 mM 2-deoxy-D-glucose, based 
on the preceding experiment, and the use of 1 mM 2-deoxy-D-glucose to explore how glycolysis affects innate 
immunity (Tannahill, et al. 2013, Zhao, et al. 2017).  
Energy stress activates AMPK, and so we treated cells for 2 h with 0.01–1 mM AICAR (5-aminoimidazole-4-
carboxamide1-beta-D-ribofuranoside; Merck) to activate AMPK (Corton, et al. 1995), as validated previously by 
showing  that AICAR-stimulated phosphorylation of AMPK in bovine granulosa cells (Tosca, et al. 2007). 
Subsequent experiments used 1 mM AICAR, based on the preceding experiment, and the use of 1 mM AICAR to 
activate AMPK in granulosa cells from rats, chickens and cattle (Tosca, et al. 2007, Tosca, et al. 2006, Tosca, et 
al. 2005), and bovine endometrial cells (Turner, et al. 2016). 
As AMPK inhibits mTOR, we also treated cells for 2 h with the mTOR complex 1 (mTORC1) inhibitor (5–500 
nM rapamycin; Merck) or the mTORC1/2 inhibitor (10–150 nM Torin 1, 1-[4-[4-(1-Oxopropyl)-1-piperazinyl]-
3-(trifluoromethyl) phenyl]-9 (3-quinolinyl)-benzo[h]-1,6-naphthyridin-2(1H)-one; Bio-Techne, Abingdon, UK), 
as described previously (Oshiro, et al. 2004, Thoreen, et al. 2009). Subsequent experiments used 500 nM 
rapamycin and 50 nM Torin 1, based on the preceding experiment, and the use of similar concentrations to 
investigate responses to LPS in human leukocytes (Zhang, et al. 2019), and the use of 100 nM Torin 1 in mouse 
granulosa cells (Shen, et al. 2017). A glucocorticoid, 1 µM dexamethasone (Merck), was used as a reference anti-
inflammatory agent (Bhattacharyya, et al. 2007). 
To explore the requirements for glucose, granulosa cells were treated for 24 h with a range of concentrations of 
glucose (0–5 mM) added to glucose-free DMEM (Thermo Fisher Scientific; glucose-free M199 medium was not 
available), supplemented with 10% heat-inactivated fetal bovine serum (supplying 0.79 mM glucose at final 
concentration), 1% Antibiotic Antimycotic Solution, 1% Insulin-Transferrin-Selenium, and 2 mM glutamine.  
After each treatment period, the cells were challenged for 24 h by adding 0.5 ml of either granulosa cell culture 
medium (control) or medium providing a final concentration of 1 μg/ml ultrapure LPS from E. coli serotype 
0111:B4 (InvivoGen, Toulouse, France), in the continuing presence of the treatments. The concentration of LPS 
and duration of challenge was based on previous experiments using a range of concentrations of 1 ng/ml to 10 
μg/ml LPS, and on IL-1β, IL-6 and IL-8 responses to 1 μg/ml LPS in bovine granulosa cells isolated from 4–8 
and > 8.5 mm diameter follicles (Bromfield and Sheldon 2011, Price, et al. 2013, Price and Sheldon 2013). As 
we hypothesised that treatments might reduce inflammation, as in murine macrophages (Tannahill, et al. 2013), 
we used a relatively high concentration of 1 μg/ml LPS to stimulate robust inflammatory responses. 
At the end of each experiment, granulosa cell supernatants were collected for the measurement of the 
representative inflammatory mediators IL-1α, IL-1β and IL-8 by enzyme-linked immunosorbent assay (ELISA), 
and cell viability and proliferation was estimated using the MTT assay or cell lysates were collected for Western 
blotting. Each experiment was repeated on at least three independent occasions, with each replicate using 
granulosa cells pooled from the ovaries of 10–20 animals. 
ELISA 
Bovine IL-1α ELISA was performed as described and validated previously (Healy, et al. 2014); using polyclonal 
rabbit anti-bovine IL-1α capture antibody (Kingfisher Biotech, Saint Paul, USA; RRID: AB_2833237), 
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recombinant IL-1α protein (Kingfisher Biotech, #RP0097B), biotinylated polyclonal anti-bovine IL-1α 
(Kingfisher Biotech; RRID: AB_2833238) and avidin HRP (Fisher Scientific; #18410051). Bovine IL-1β ELISA 
was performed using a kit according to the manufacturer’s instructions (Thermo Fisher Scientific; RRID: 
AB_2833244). Bovine IL-8 ELISA was performed as described and validated previously (Cronin, et al. 2015); 
using monoclonal anti-ovine IL-8 capture antibody (Bio-Rad, Hercules, CA, USA; RRID: AB_322152), 
recombinant IL-8 protein (Kingfisher Biotech; #RP0023B), polyclonal rabbit anti-sheep IL-8 detection antibody 
(Bio-Rad; RRID: AB_322153) and HRP-conjugated goat anti-rabbit antibody (Dako, Glostrup, Denmark; RRID: 
AB_2617138). The limits of detection were 12.5 pg/ml for IL-1α, 31.3 pg/ml for IL-1β, and 62.5 pg/ml for IL-8; 
the inter-assay and intra-assay coefficients of variation were all < 7% and < 9%, respectively. 
MTT assay 
The MTT assay has been used previously as an indicator of cell viability, proliferation and cytotoxicity following 
treatment with 2-deoxy-D-glucose, AICAR, rapamycin and Torin 1 (Aft, et al. 2002, Giubellino, et al. 2013, Kim, 
et al. 2008). Granulosa cell MTT assays were performed as described previously (Price, et al. 2013). Briefly, after 
supernatants were collected, cells were incubated for 1 h in granulosa cell culture medium containing 0.5 mg/ml 
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium; Merck). The supernatants were discarded, the cells 
lysed using dimethyl sulfoxide (Merck), and optical density measured at 570 nm (OD570) using a POLARstar 
Omega plate reader (BMG Labtech, Ortenberg, Germany). 
Western blotting 
First, we explored the effects of the treatments alone on p70 S6 kinase (p70S6K also known as ribosomal protein 
S6 kinase beta-1), which induces proteins synthesis at ribosomes (Kimura, et al. 2003), and acetyl-CoA 
carboxylase, which is a downstream target of AMPK and the biomarker for AMPK activation (González, et al. 
2020, Hardie, et al. 2012). Granulosa cells from 4–8 mm or > 8.5 mm diameter ovarian follicles were treated for 
0, 10, 20, 30, 60 or 120 min with 1 mM AICAR to examine activation of acetyl-CoA carboxylase, or for 24 h 
with vehicle, 1 mM 2-deoxy-D-glucose, 1 mM AICAR, 500 nM rapamycin or 50 nM Torin 1; the effect of 1 
µg/ml LPS was also examined.  
Secondly, we explored the effects of AICAR or Torin 1 treatment followed by LPS challenge on MAPK 
signalling, because LPS induces MAPK signalling in granulosa cells (Bromfield and Sheldon 2011, Price, et al. 
2013). Granulosa cells from 4–8 mm or > 8.5 mm diameter ovarian follicles were treated for 2 h with granulosa 
cell culture medium containing vehicle, or 1 mM AICAR or 50 nM Torin 1, and then challenged for 0, 10, 20, 30, 
60 or 120 min with medium containing a final concentration of 1 μg/ml LPS. 
At the end of these experiments, the cells were washed with 300 μl/well of ice-cold phosphate buffered saline 
(PBS; Gibco) and lysed with 100 μl/well PhosphoSafe Extraction Reagent (Novagen, Darmstadt, Germany), 
followed by protein extraction and quantification (DC assay; Bio-Rad). Proteins (10 μg) were electrophoresed on 
a 10% or 12% polyacrylamide gel, transferred onto a polyvinylidene difluoride membrane (GE Healthcare, 
Chalfont, St Giles, UK), blocked for 1 h in 5% BSA in Tris-buffered saline-Tween 20 (TBS-Tween), and probed 
overnight with primary antibodies diluted 1:1000 in 5% BSA TBS-Tween. The primary antibodies were phospho-
p70 S6 kinase (Cell Signaling, Danvers, MA, USA; RRID: AB_2269803), p70 S6 kinase (Cell Signaling; RRID: 
AB_331676), phospho-ACC (Cell Signaling; RRID: AB_330337), ACC (Cell Signaling; RRID: AB_2219400), 
phospho-AMPK Thr172 (Cell Signaling; RRID: AB_331250), AMPK (Cell Signaling; RRID: AB_10622186), 
diphosphorylated ERK1/2 (Merck; RRID: AB_477245), ERK1/2 (Abcam, Cambridge, UK; RRID: 
AB_2297336), phospho-JNK (Cell Signaling; RRID: AB_331659), and JNK (Cell Signaling; RRID: 
AB_2250373). After three 5 min washes in TBS-Tween, membranes were incubated for 60 min with 1:2500 
dilution HRP-linked anti-mouse IgG (Cell Signaling; RRID: AB_330924) or anti-rabbit IgG (Cell Signaling; 
RRID: AB_2099233). After a final 3 washes, protein reactivity was assessed by enhanced chemiluminescence 
(Clarity Western ECL substrate; Bio-Rad). After imaging, membranes were stripped for 7 min with Restore 
Western Blot Stripping Buffer (Fisher Scientific) and re-probed with another primary antibody, or with 1:1000 
dilution β-actin (Abcam; RRID: AB_306371) or α-tubulin (Cell Signalling; RRID:AB_2619646) to normalize 
protein loading. Images of whole blots were captured using a ChemiDoc XRS System (Bio-Rad; Supplemental 
Figure 1). The background-normalized peak band density was measured in the images for each protein using Fiji 
(Schindelin, et al. 2012); target protein bands were normalized to β-actin or α-tubulin, and phosphorylated proteins 




The statistical unit was each independent culture of granulosa cells. Statistical analysis was performed using 
GraphPad Prism version 8.4.2 (GraphPad Software, San Diego, California, USA). Data were analysed using one-
way or two-way ANOVA, as reported in Results, followed by Dunnett’s post hoc tests. Data are presented as dot 
plots or as arithmetic mean (SEM), and P < 0.05 was considered significant. 
Results 
Inhibiting glycolysis reduced granulosa cell inflammatory responses to LPS 
Granulosa cell defences are important if ovarian follicles are exposed to LPS during the postpartum period, and 
yet there is often concurrent energy stress (Beam and Butler 1997, Cheong, et al. 2017, Herath, et al. 2007, Leroy, 
et al. 2004, Piersanti, et al. 2019). We first used 2-deoxy-D-glucose to inhibit glycolysis and model energy stress, 
and ultrapure LPS from E. coli to stimulate inflammatory responses in granulosa cells, as described previously 
(Hirschfeld, et al. 2000, Lee, et al. 2020, Price, et al. 2013, Tannahill, et al. 2013, Zhao, et al. 2017). Granulosa 
cells, isolated from 4–8 mm or from > 8.5 mm diameter follicles, were treated with vehicle or 2-deoxy-D-glucose 
for 2 h prior to and then during a 24 h challenge with control medium or medium containing 1 µg/ml LPS. The 
LPS challenge stimulated inflammatory responses, with higher concentrations of IL-1α, IL-1β and IL-8 in cell 
supernatants compared with the control challenge in granulosa cells from 4–8 mm (P < 0.001; Fig. 1) and > 8.5 
mm diameter follicles (P < 0.001; Fig. 2). However, treating granulosa cells with 2-deoxy-D-glucose reduced 
LPS-stimulated IL-1α, IL-1β, and IL-8, without significantly altering cell viability, in granulosa cells from both 
4–8 mm (Fig. 1A–D) and > 8.5 mm diameter follicles (Fig. 2A–D). Specifically, compared with vehicle, treatment 
with 500 µM 2-deoxy-D-glucose reduced LPS-stimulated IL-1α by > 80%, IL-1β by > 90%, and IL-8 by > 65% 
for cells from 4–8 mm and > 8.5 mm diameter follicles. 
 
Figure 1. Inhibiting glycolysis limits LPS-stimulated inflammation in granulosa cells. 
Granulosa cells isolated from 4–8 mm diameter ovarian follicles were cultured with vehicle (V), or the indicated 
final concentrations of 2-deoxy-D-glucose for 2 h (2-DG, A–D), or the indicated concentrations of glucose for 24 
h (E–H); followed by a 24 h challenge with control medium (○) or medium containing 1 µg/ml LPS (●), in the 
presence of the treatments. Supernatant IL-1α (A, E), IL-1β (B, F) and IL-8 (C, G) was measured by ELISA, and 
cell viability assessed by MTT assay (D, H). Data from independent experiments are presented as dot plots, with 
bars indicating the mean (SEM). Data were analysed by two-way ANOVA, and P-values reported for the effect 
of treatment on responses to LPS. 
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Although inhibiting glycolysis has widespread effects on metabolic pathways and inflammation (Murray, et al. 
2015, O'Neill, et al. 2016), one consideration was that limiting glucose may be sufficient to reduce inflammatory 
response to LPS. Thus, we treated granulosa cells for 24 h with a range of concentrations of glucose (0 to 5 mM) 
added to glucose-free culture medium, in the presence of 2 mM glutamine and 10% fetal bovine serum (supplying 
0.79 mM glucose), followed by a 24 h challenge with control medium or medium containing 1 µg/ml LPS. 
However, glucose did not significantly alter LPS-stimulated IL-1α, IL-1β or IL-8, or alter the viability of 
granulosa cells from either 4–8 mm (Fig. 1E–H) or > 8.5 mm diameter follicles (Fig. 2E–H). These data provide 
evidence that inhibiting glycolysis to mimic energy stress limited LPS-induced inflammation in granulosa cells 
from both 4–8 mm and > 8.5 mm diameter follicles, but inflammation was not simply dependent on the glucose 
supply. 
 
Figure 2. Inhibiting glycolysis limits LPS-stimulated inflammation in granulosa cells. 
Granulosa cells isolated from > 8.5 mm diameter ovarian follicles were cultured with vehicle (V), or the indicated 
final concentrations of 2-deoxy-D-glucose for 2 h (2-DG, A–D), or the indicated concentrations of glucose for 24 
h (E–H); followed by a 24 h challenge with control medium (○) or medium containing 1 µg/ml LPS (●), in the 
presence of the treatments. Supernatant IL-1α (A, E), IL-1β (B, F) and IL-8 (C, G) was measured by ELISA, and 
cell viability assessed by MTT assay (D, H). Data from independent experiments are presented as dot plots, with 
bars indicating the mean (SEM). Data were analysed by two-way ANOVA, and P-values reported for the effect 
of treatment on responses to LPS. 
AMPK and mTOR reduced granulosa cell inflammatory responses to LPS 
Cellular energy metabolism is regulated by AMPK and mTOR, with energy stress activating AMPK and inhibiting 
mTOR (Hardie, et al. 2012, Zoncu, et al. 2011). To screen for effects of AMPK and mTOR, granulosa cells were 
treated for 2 h prior to and during a 24 h LPS challenge, with 1 mM AICAR to activate AMPK, 500 nM rapamycin 
to inhibit mTORC1, or 50 nM Torin 1 to inhibit mTORC1 and mTORC2; 1 µM dexamethasone was used as a 
reference anti-inflammatory agent (Bhattacharyya, et al. 2007). As before, LPS stimulated increased IL-1α, IL-
1β and IL-8 compared with control (P < 0.001; Fig. 3). However, treatment with AICAR reduced LPS-stimulated 
IL-1α, IL-1β and IL-8 in granulosa cells from 4–8 mm and > 8.5 mm diameter follicles (P < 0.05), and AICAR 
was at least as effective as dexamethasone. Rapamycin did not reduce LPS-stimulated inflammation, but Torin 1 
reduced IL-1α and IL-1β in granulosa cells from 4–8 mm and > 8.5 mm diameter follicles (P < 0.05). 








































































































































































A B C D




Figure 3. Intracellular metabolic sensors and granulosa cell inflammation. 
Granulosa cells from 4–8 mm (A–C) or > 8.5 mm diameter ovarian follicles (D–F) were cultured for 2 h with 
vehicle, 1 mM AICAR, 500 nM rapamycin, 50 nM Torin 1, or 1 µM dexamethasone; followed by a 24 h challenge 
with control medium (○) or medium containing 1 µg/ml LPS (●), in the presence of the treatments. Supernatant 
IL-1α (A, D), IL-1β (B, E) and IL-8 (C, F) was measured by ELISA. Data from independent experiments are 
presented as dot plots, with bars indicating the mean (SEM). Data were analysed by two-way ANOVA, with 
Dunnett’s post hoc test, and P-values differ between vehicle and treatments for the response to LPS. 
 
We next considered whether reducing inflammation by inhibiting glycolysis, activating AMPK, or inhibiting 
mTOR simply reflected reduced protein synthesis, because these treatments can reduce phosphorylation of 
p70S6K, which induces protein synthesis (Kimura, et al. 2003). In granulosa cells from 4–8 mm and > 8.5 mm 
diameter follicles, rapamycin and Torin 1 alone reduced the abundance of phosphorylated p70S6K (Fig. 4). 
Although, there was phosphorylated p70S6K in the vehicle treatment, which might be associated with 
supplementation of the culture medium with serum and Insulin-Transferrin-Selenium, treatment with LPS, 2-
deoxy-D-glucose or AICAR did not significantly alter phosphorylation of p70S6K. Furthermore, our findings 
were supported by experiments where Torin 1 but not AICAR reduced the amount of protein per culture well in 
granulosa cells from 4–8 mm diameter follicles (Torin 1, 1.49 ± 0.04 mg protein vs. AICAR, 2.03 ± 0.06 mg or 
control, 2.19 ± 0.12 mg; P < 0.05, ANOVA, n = 4), and > 8.5 mm diameter follicles (Torin 1, 1.32 ± 0.12 mg 
protein vs. AICAR, 1.52 ± 0.05 mg or control, 1.51 ± 0.09 mg; P < 0.05, ANOVA, n = 4). Together, these 
observations suggest that activating AMPK may limit granulosa cell inflammatory responses to LPS 








































































































































































































































Figure 4. Rapamycin and Torin 1 reduce the phosphorylation of p70S6K. 
Granulosa cells from 4–8 mm (A) or > 8.5 mm diameter ovarian follicles (B) were treated for 24 h in culture 
medium with vehicle, 1µg/ml LPS, 1 mM 2-deoxy-D-glucose (2-DG), 1 mM AICAR, 500 nM rapamycin or 50 
nM Torin 1, and the phosphorylation of p70 S6 kinase (p70S6K) analysed by Western blot. Left panels show 
representative Western blots of phosphorylated p70S6K, total p70S6K and β-actin (Supplemental Figure 1); right 
panels provide quantification of band densities for phosphorylated p70S6K relative to total p70S6K. Data from 
independent experiments are presented as dot plots, with bars indicating the mean (SEM). Data were analysed by 
one-way ANOVA, with Dunnett’s post hoc test, and P-values reported for differences between the vehicle and 
treatments. 
AICAR limited granulosa cell responses to LPS 
To further investigate the effect of manipulating cellular energy metabolism, we used AICAR to activate AMPK 
(Corton, et al. 1995); as validated previously in bovine granulosa cells by AICAR-induced phosphorylation of 
AMPK (Tosca, et al. 2007). We confirmed the activity of AICAR in granulosa cells by evaluating the 
phosphorylation of acetyl-CoA carboxylase (ACC), which is the biomarker for activation of AMPK (González, 
et al. 2020, Hardie, et al. 2012). Treating granulosa cells from both 4–8 mm and > 8.5 mm diameter follicles with 
AICAR induced phosphorylation of ACC within 2 h (Fig. 5A), as well as phosphorylation of AMPK 
(Supplemental Figure 1). In addition, the phosphorylation of ACC was still evident after treating cells with 
AICAR for 24 h (Fig. 5B); although, LPS, 2-deoxy-D-glucose, rapamycin or Torin 1 did not significantly alter 
ACC phosphorylation. We next treated granulosa cells with a range of concentrations of AICAR for 2 h prior to 
and during a 24 h LPS challenge. Treatment with AICAR reduced LPS-stimulated IL-1α, IL-1β, and IL-8, without 
significantly altering cell viability (Fig. 5C–J). Specifically, compared with vehicle, treatment with 0.5 mM 
AICAR reduced LPS-stimulated IL-1α by > 60%, IL-1β by > 75%, and IL-8 by > 20% in granulosa cells from 






























































































































































Figure 5. AICAR limits LPS-stimulated inflammation in granulosa cells. 
Granulosa cells from 4–8 mm or > 8.5 mm diameter ovarian follicles were treated in culture medium with vehicle, 
or for the indicated times with 1 mM AICAR (A), or for 24 h with 1 µg/ml LPS, 1 mM 2-deoxy-D-glucose (2-
DG), 1 mM AICAR, 500 nM rapamycin or 50 nM Torin 1 (B), and the phosphorylation of acetyl-CoA carboxylase 
(ACC) analysed by Western blot. Representative Western blots of phosphorylated ACC, total ACC, and β-actin 
or α-tubulin are shown (left panel; Supplemental Figure 1); with quantification of band densities for 
phosphorylated relative to total ACC (right panel). Data from independent experiments are presented as dot plots, 
with bars indicating the mean (SEM). Data were analysed by ANOVA, with Dunnett’s post hoc test, and P-values 
reported. Granulosa cells from 4–8 mm (C–F) or > 8.5 mm diameter follicles (G–J) were treated for 2 h with 
culture medium containing vehicle (V) or the indicated final concentrations of AICAR, followed by a 24 h 
challenge with control medium or medium containing 1 µg/ml LPS, in the presence of the treatments. Supernatant 
IL-1α (C, G), IL-1β (D, H) and IL-8 (E, I) were measured by ELISA. Cell viability was assessed by MTT assay 
(F, J). Data from independent experiments are presented as dot plots, with bars indicating the mean (SEM). Data 
were analysed by two-way ANOVA, and P-values reported for the effect of AICAR on the response to LPS. 
AICAR truncates LPS-stimulated phosphorylation of ERK and JNK  
We then explored whether treatment with AICAR altered the MAPK response to LPS, which stimulates ERK1/2 
phosphorylation in granulosa cells within 30 min (Bromfield and Sheldon 2011, Price, et al. 2013, Price and 
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challenged for up to 120 min with LPS. There was LPS-stimulated ERK1/2 phosphorylation in granulosa cells 
from 4–8 mm diameter follicles (Fig. 6A) and from > 8.5 mm diameter follicles (Fig. 6B). Although there was no 
significant effect of AICAR treatment, there was a shorter duration of ERK1/2 phosphorylation in cells treated 
with AICAR than vehicle for cells from 4–8 mm diameter (time × treatment, P < 0.001), and for cells from > 8.5 
mm diameter follicles (time × treatment, P < 0.05).  
We additionally examined the phosphorylation of JNK, which was stimulated by LPS in granulosa cells from 4–
8 mm diameter follicles (Fig. 6A) and from > 8.5 mm diameter follicles (Fig. 6B). Treatment with AICAR also 
stimulated JNK phosphorylation in granulosa cells from both follicles. However, there was a shorter duration of 
JNK phosphorylation in cells treated with AICAR than vehicle for cells from 4–8 mm diameter (time × treatment, 
P < 0.05), and for cells from > 8.5 mm diameter follicles (time × treatment, P < 0.01). These experiments provide 
evidence that AICAR reduced inflammatory responses to LPS, and truncated the LPS-stimulated phosphorylation 
of ERK1/2 and JNK. 
 
Figure 6. AICAR truncates LPS-stimulated phosphorylation of ERK and JNK. 
Granulosa cells from 4–8 mm (A) or > 8.5 mm diameter ovarian follicles (B) were treated with vehicle or 1 mM 
AICAR for 2 h and then challenge with 1 µg/ml LPS for the indicated time, and the phosphorylation of ERK1/2 
and JNK analysed by Western blot. Upper panels show representative Western blots of phosphorylated and total 
ERK1/2, phosphorylated and total JNK, and β-actin (Supplemental Figure 1); lower panels provide quantification 
of band densities for phosphorylated relative to total ERK1/2 and JNK. Data are presented as mean (SEM) from 
4 independent experiments; statistical significance was determined using two-way ANOVA and P-values 
reported. 
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Torin 1 limited granulosa cell IL-1 responses to LPS 
We finally considered whether inhibiting mTOR would also reduce inflammatory responses to LPS because 
activating AMPK in turn inhibits mTOR (Hardie, et al. 2012, Zoncu, et al. 2011). Granulosa cells were treated 
for 2 h with vehicle, or a range of concentrations of the dual mTORC1 and mTORC2 inhibitor Torin 1 (Thoreen, 
et al. 2009), or the mTORC1 inhibitor rapamycin (Oshiro, et al. 2004), followed by a 24 h control or LPS 
challenge, in the presence of the treatments (Fig. 7). Treatment with Torin 1 reduced LPS-stimulated IL-1α and 
IL-1β, but not IL-8, in cells from 4–8 mm diameter follicles (Fig. 7A–C) and from > 8.5 mm diameter follicles 
(Fig. 7E–G). Specifically, compared with vehicle, treatment with 50 nM Torin 1 reduced LPS-stimulated IL-1α 
by > 65% and IL-1β by > 50% in the supernatants of granulosa cells from 4–8 mm and > 8.5 mm diameter follicles. 
Although the highest concentrations of Torin 1 reduced cell viability by up to 10% (Fig. 7D, H), treatment with 
50 nM Torin 1 did not significantly alter cell viability of granulosa cells from 4–8 mm diameter follicles (P = 
0.53) or from > 8.5 mm diameter follicles (P = 0.99). Rapamycin did not significantly alter the inflammatory 
responses to LPS in cells from 4–8 mm diameter follicles or from > 8.5 mm diameter follicles and did not 
significantly alter cell viability (Fig. 7I–P). 
 
Figure 7. Torin 1 limits LPS-stimulated inflammation in granulosa cells. 
Granulosa cells from 4–8 mm (A–D, I–L) or > 8.5 mm diameter ovarian follicles (E–H, M–P) were treated for 2 
h with culture medium containing vehicle (V), or the indicated final concentrations of Torin 1 or rapamycin; 
followed by a 24 h challenge with control medium or 1 µg/ml LPS, in the presence of the treatments. Supernatant 
IL-1α, (A, E, I, M), IL-1β (B, F, J, N) and IL-8 (C, G, K, O) was measured by ELISA; cell viability was assessed 
by MTT assay (D, H, L, P). Data from independent experiments are presented as dot plots, with bars indicating 
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the mean (SEM). Data were analysed by one-way ANOVA, and P-values are reported for the effect of treatment 
on the LPS response. 
 
As Torin 1 reduced inflammation, we next explored whether Torin 1 altered LPS-stimulated phosphorylation of 
MAPK. Granulosa cells were treated for 2 h with vehicle or 50 nM Torin 1, and then challenged for up to 120 
min with LPS. As before, LPS stimulated phosphorylation of ERK1/2 and JNK in granulosa cells from 4–8 mm 
diameter follicles (Fig. 8A), and from > 8.5 mm diameter follicles (Fig. 8B). However, Torin 1 did not 
significantly alter the duration of ERK1/2 or JNK phosphorylation. Together, these data suggest that whilst Torin 
1 reduced IL-1 responses to LPS, Torin 1 did not alter the duration of MAPK phosphorylation. 
 
Figure 8. Torin 1 did not alter LPS-stimulated phosphorylation of MAPK. 
Granulosa cells from 4–8 mm (A) or > 8.5 mm diameter ovarian follicles (B) were treated with vehicle or 50 nM 
Torin 1 for 2 h and then challenge with 1 µg/ml LPS for the indicated times, and the phosphorylation of ERK1/2 
and JNK analysed by Western blot. Upper panels show representative Western blots of phosphorylated and total 
ERK1/2, phosphorylated and total JNK, and β-actin (Supplemental Figure 1); lower panels provide quantification 
of band densities for phosphorylated relative to total ERK1/2 and JNK. Data are presented as mean (SEM) from 
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Innate immunity and energy stress are both important in granulosa cells because ovarian follicles are often exposed 
to LPS after parturition, which is when cows are unable to consume enough food to meet their energy demands 
(Beam and Butler 1997, Cheong, et al. 2017, Herath, et al. 2007, Leroy, et al. 2004, Piersanti, et al. 2019). In the 
present study, we found that LPS stimulated phosphorylation of ERK1/2 and JNK, and stimulated the release of 
IL-1α, IL-1β and IL-8. However, our main finding was that energy stress limited inflammation in bovine granulosa 
cells. Inflammatory responses to LPS were limited by the glycolysis inhibitor 2-deoxy-D-glucose, the AMPK 
activator AICAR, or the mTOR inhibitor Torin 1. Furthermore, AICAR truncated LPS-stimulated 
phosphorylation of ERK1/2 and JNK. The effects of manipulating energy metabolism on the responses to LPS 
were similar for granulosa cells isolated from both 4–8 mm and > 8.5 mm diameter ovarian follicles. Collectively, 
the data provide evidence for an immunometabolism crosstalk in granulosa cells and imply that energy stress 
limits ovarian follicle defences. 
We first generated energy stress by inhibiting hexokinase with 2-deoxy-D-glucose to prevent glycolysis (Lee, et 
al. 2020, Tannahill, et al. 2013, Zhao, et al. 2017). Inhibiting glycolysis reduced LPS-stimulated IL-1α, IL-1β, 
and IL-8 in granulosa cells from 4–8 mm and > 8.5 mm diameter ovarian follicles. This reduced inflammation is 
similar to findings with murine macrophages, where inhibiting hexokinase reduces LPS-stimulated IL-1β 
(Tannahill, et al. 2013). Inhibiting hexokinase or depleting glucose and glutamine, also limits LPS-stimulated 
IL-1β, IL-6 and IL-8 in bovine endometrial tissue (Noleto, et al. 2017, Turner, et al. 2016). When follicular 
fluid was collected from cows 63 days post partum, intrafollicular IL-8 and LPS concentrations were correlated 
as might be expected, but more interestingly intrafollicular IL-8 and glucose concentrations were also correlated 
(r2 = 0.77) (Piersanti, et al. 2019). Transcriptomic analysis has also suggested that energy stress impairs 
inflammatory responses to LPS in granulosa cells collected from postpartum cows (Girard, et al. 2015). 
Cellular energy metabolism is regulated by AMPK and mTOR in most eukaryotic cells (Hardie, et al. 2012, 
Murray, et al. 2015, O'Neill, et al. 2016, Zoncu, et al. 2011). The energy sensor AMPK is activated by energy 
stress or by small molecules such as AICAR (Hardie, et al. 2012, Tosca, et al. 2007, Tosca, et al. 2010). Activating 
AMPK regulates energy metabolism by stimulating glucose uptake, glycolysis and the Krebs cycle to produce 
ATP (Hardie, et al. 2012). Activating AMPK also inhibits mTOR and pathways that consume ATP, including 
inhibition of lipid metabolism via phosphorylation of acetyl-CoA carboxylase. In the present study, AICAR 
increased phosphorylation of acetyl-CoA carboxylase, confirming previous observations that AICAR activates 
AMPK in bovine granulosa cells (Tosca, et al. 2007). More importantly, treatment with AICAR reduced LPS-
stimulated IL-1α, IL-1β and IL-8 in granulosa cells, with 0.5 mM AICAR reducing LPS-stimulated IL-1α by > 
60%, IL-1β by > 75%, and IL-8 by > 20%. Our finding agrees with previous observations that AICAR reduces 
LPS-stimulated TNF-α and IL-6 in murine neutrophils, and IL-1β, IL-6 and IL-8 in bovine endometrial tissue 
(Turner, et al. 2016, Zhao, et al. 2008). Surprisingly, the responses to LPS and the effects of energy stress in the 
present study were similar for granulosa cells from both 4–8 mm and > 8.5 mm diameter ovarian follicles, despite 
developmental differences between these follicle sizes (Fortune 1994, Ginther, et al. 1996). This consistent 
immunometabolism effect may reflect the evolutionary importance of integrating defence with metabolism. 
One concern was that the reductions in inflammation were simply caused by reduced protein synthesis. However, 
AICAR did not inhibit phosphorylation of p70S6K or reduce total cellular protein. Instead, AICAR reduced the 
duration of LPS-stimulated phosphorylation of ERK1/2 and JNK. This observation is similar to a reduction in 
FSH-induced phosphorylation of ERK1/2, when bovine granulosa cells were treated with metformin, which also 
activates AMPK (Tosca, et al. 2007, Tosca, et al. 2010).  
Activating AMPK can in turn regulate energy metabolism by inhibiting mTOR (Hardie, et al. 2012, Zoncu, et al. 
2011). We found that granulosa cell IL-1α and IL-1β responses to LPS were reduced by Torin 1, but not by 
rapamycin, and MAPK phosphorylation was unaffected. The different IL-1 responses between Torin 1 and 
rapamycin may be because Torin 1 inhibits both mTORC1 and mTORC2, whereas rapamycin inhibits only 
mTORC1 (Oshiro, et al. 2004, Thoreen, et al. 2009). Another possibility is that Torin 1 reduced LPS-stimulated 
inflammation by more effectively reducing protein synthesis, because Torin 1 reduced the phosphorylation of 
p70S6K and the amount of cellular protein. 
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The observation was that depleting glucose did not limit inflammatory responses to LPS was unexpected because 
responses to LPS are energetically expensive (Kvidera, et al. 2017). The lack of effect of glucose depletion on 
granulosa cell inflammation might be because the fetal bovine serum in the culture medium supplied 0.79 mM 
glucose, or because of the metabolic flexibility of cells to use alternative energy sources, including glutamine and 
lipids (Reitzer, et al. 1979). Another explanation might be because directly inhibiting glycolysis with 2-deoxy-D-
glucose has widespread impacts on cell metabolism (O'Neill, et al. 2016, Tannahill, et al. 2013). Future studies 
could investigate whether components of the glycolysis pathway or Krebs cycle impinge directly on granulosa 
cell inflammatory responses because acetyl-CoA, succinate and fumarate all regulate inflammation in immune 
cells (Ryan, et al. 2019). Another intriguing observation worthy of further investigation is that whilst AICAR, 
Torin 1 and dexamethasone reduced LPS-stimulated IL-1, only AICAR reduced IL-8, which may reflect 
differences in the regulation of IL-1 and IL-8 production or secretion (Hoffmann, et al. 2002). 
In conclusion, granulosa cell inflammatory responses to LPS were limited by manipulating cellular energy 
metabolism using a glycolysis inhibitor, an AMPK activator, or an mTOR inhibitor. Specifically, in cells isolated 
from ovarian follicles 4–8 mm and > 8.5 mm diameter, 2-deoxy-D-glucose and AICAR limited LPS-stimulated 
IL-1α, IL-1β and IL-8, and Torin 1 limited IL-1α and IL-1β. These observations are an example of 
immunometabolism, linking cellular energy metabolism with innate immunity in granulosa cells. Our findings 
also imply that energy stress compromises ovarian follicle immune defences, which may reduce the capability of 
cows to cope with the effect of infections on fertility. 
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